The Gram-positive bacterium Clostridioides difficile is a primary cause of hospital-acquired diarrhea, threatening both immunocompromised and healthy individuals. An important aspect of elucidating mechanisms that drive C. difficile persistence and virulence relies on developing a more complete understanding of sporulation. C. difficile sporulation is the single determinant of transmission and complicates treatment and prevention due to the chemical and physical resilience of spores. Hence, the identification of potentially druggable targets that significantly attenuate sporulation is important. In this report, we describe the impact of the loss of caseinolytic protease P (ClpP) isoforms in C. difficile strain 630 on sporulation phenotypes. Using CRISPR-Cas9 nickase mediated genome editing, stop codons were inserted early in the coding sequence for clpP1 and clpP2 to generate C. difficile mutants that no longer produced ClpP1 or ClpP2. The data show that these genetic modifications lead to altered sporulation phenotypes, germination efficiencies, and cytotoxicity. Comparative proteome profiling of C. difficile 630 WT and clpP mutants reveals potential proteolytic targets of ClpP that are involved in sporulation. These analyses further reveal the potential for preferred co-chaperone interactions for each ClpP isoform. Taken together, our results demonstrate that ClpP, a promising target in other Gram-positive pathogens, holds promise as an anti-sporulation target in C. difficile .
Many questions remain about the exact role major virulence factors TcdA and TcdB play during Clostridium difficile infection (CDI). It is known that TcdB is required for CDI, but we still lack a detailed understanding of how and/or why TcdB is cytotoxic and cytopathic. Wei et al. focus on TcdB, a cytotoxin that is secreted by C. difficile, after CDI has been established, which kills intestinal epithelial cells and leads to life-threatening pseudomembranous colitis. This work demonstrates that TcdB glucosyltransferase activity is required for inducing unregulated autophagy, leading to cellular death. For the first time, a link between glucosyltransferase enzymatic activity and host autophagy is established for this pathogenic and problematic bacterium.
Compelling evidence is reported that bacteria utilize arginine phosphorylation as a degradation tag/signal, akin to ubiquitination in eukaryotes, to regulate protein turnover. Through robust quantitative proteomic and biochemical analyses, Clausen et al. identify a degradation-tagging mechanism that relies on a polyphosphorylation of arginine residues to mark a protein for degradation. This enables, ClpC, a cochaperone of caseinolytic protease P (ClpP), to specifically recognize, and facilitate the degradation of tagged proteins. This is a significant step forward in understanding protein turnover in bacteria.
This paper identifies methodological improvements in ReAsH technology, which allows for the quantification of intracellular protein folding kinetics and thermodynamics. The finding is significant, as it provides new innocuous tagging approaches that are less likely than larger fluorophores (e.g. GFP, m-Cherry) to interfere with natural protein behavior.
Sello, Mylonakis, and colleagues perform in vivo efficacy and toxicity experiments with ADEP B315, a rigid acyldepsipeptide activator of bacterial caseinolytic protease P (ClpP). In these experiments, ADEP B315 was shown to increase the survival rates of mice challenged by lethal intraperitoneal injections of methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA). The findings in this paper are significant, as they provide further evidence that ClpP activators can exhibit efficacy and low toxicity in vivo. This work builds upon the in vivo data generated by Brotz-Oesterhelt et al. in 2005 {1} and Conlon et al. in 2013 {2}, and provides impetus for the continued exploration of ClpP activation as a differentiated antibacterial strategy.